MYT1L and in situ carcinoma: Of the 17 CIS genes, 9 show significantdifferential expression when SHH subgroup tumours are compared to all others(including MYT1L and PTEN discussed above), and 15 showdifferential expression in one or more clinicogenetic subgroups(Table 2).